News | Radiation Therapy | September 09, 2019

Synchrony motion tracking for Radixact System, CyberKnife VOLO Optimizer among radiation therapy treatment system highlights

Accuray to Display Motion Synchronization Cancer Treatment Technologies at ASTRO 2019

September 9, 2019 — Accuray announced that it will showcase its motion-synchronization cancer treatment technologies at the upcoming 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 15 - 18 in Chicago. The company will provide multiple opportunities for attendees to explore its new innovations in patient-first cancer treatments, including booth presentations and demonstrations at its Innovation Pavilion and presentations at the Accuray Symposium.

Synchrony Motion Tracking and Correction Technology for the Radixact System to be Unveiled

Accuray has brought its Synchrony motion synchronization technology from the CyberKnife System to the Radixact System. During the meeting, attendees will have the chance to learn how Synchrony for Radixact synchronizes the treatment delivery beam with the movement of the tumor, accurately delivering high doses of radiation directly to the tumor and minimizing dose to healthy tissue, all while the patient breathes naturally. 

Faster Radiation Treatments with the CyberKnife System

Meeting attendees can also hear more about the CyberKnife VOLO Optimizer, a next-generation optimizer that enables physicians to significantly improve operational efficiency by reducing both the time to create high quality treatment plans and the time it takes to deliver patient treatments. Clinicians now have an option for delivering the same highly precise radiosurgery and stereotactic body radiation therapy (SBRT) treatments of the CyberKnife System, more quickly and for a wider range of patient cases.

Accuray Symposium: Clinicians to Share Treatment Perspectives

At Accuray's Symposium event on, ASTRO meeting attendees will hear how dynamic tracking and motion synchronization has translated into improved patient outcomes. The symposium panelists will discuss their perspectives and share best practices on how they have used Accuray's motion synchronization technologies.

Symposium panelists will include:

  • Symposium Chairman and Introduction: Iris C. Gibbs, M.D., FACR, FASTRO, Stanford University Medical Center, Stanford, Calif.;

  • Clinical Value of Motion Synchronization for Prostate SBRT: Ronald C. Chen, M.D. MPH, University of North Carolina, Chapel Hill;

  • Clinical Value of Motion Synchronization for Lung SBRT: Jonathan W. Lischalk, M.D., Medstar Georgetown University Hospital, Washington, D.C.; and

  • First Site Experience on Real-time Motion Synchronization on the Radixact System: X. Allen Li, Ph.D., DABMP, FAAPM, Medical College of Wisconsin.

Accuray will also feature ongoing interactive discussions with industry experts in its AERO Academy. 

For more information: www.accuray.com


Related Content

News | Radiopharmaceuticals and Tracers

September 27, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 27, 2023
arrow
News | Radiation Therapy

September 27, 2023 — The American Society for Radiation Oncology (ASTRO) announced the three winning research proposals ...

Time September 27, 2023
arrow
News | Breast Imaging

September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...

Time September 27, 2023
arrow
Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
arrow
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
News | Ultrasound Imaging

September 8, 2023 — When diagnosing and treating cancer patients, the dynamics of blood flow to and from a suspected ...

Time September 08, 2023
arrow
News | Radiation Oncology

September 6, 2023 — Nina D’Abreo, MD, has been named as chief of the Division of Hematology and Medical Oncology at NYU ...

Time September 06, 2023
arrow
Subscribe Now